zotepine (BioDeep_00000016634)
代谢物信息卡片
zotepine
化学式: C18H18ClNOS (331.07975680000004)
中文名称: 佐替平
谱图信息:
最多检出来源 () 0%
分子结构信息
SMILES: ClC1=CC=C(SC2=CC=CC=C2C=C3OCCN(C)C)C3=C1
InChI: InChI=1S/C18H18ClNOS/c1-20(2)9-10-21-16-11-13-5-3-4-6-17(13)22-18-8-7-14(19)12-15(16)18/h3-8,11-12H,9-10H2,1-2H3
描述信息
D002492 - Central Nervous System Depressants > D014149 - Tranquilizing Agents > D014150 - Antipsychotic Agents
D002491 - Central Nervous System Agents > D011619 - Psychotropic Drugs > D014149 - Tranquilizing Agents
D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants
C78272 - Agent Affecting Nervous System > C66885 - Serotonin Antagonist
C78272 - Agent Affecting Nervous System > C66883 - Dopamine Antagonist
N - Nervous system > N05 - Psycholeptics > N05A - Antipsychotics
Zotepine, an antipsychotic agent, is a potent antagonist of 5-HT2A, 5-HT2C, Histamine H1, α1-adrenergic and Dopamine D2 receptors, with Kds of 2.6 nM, 3.2 nM, 3.3 nM, 7.3 nM and 8 nM, respectively. Zotepine exhibits antidepressive and anxiolytic effects in vivo[1][2].
同义名列表
1 个代谢物同义名
数据库引用编号
11 个数据库交叉引用编号
- ChEBI: CHEBI:32316
- KEGG: C12752
- KEGGdrug: D01321
- PubChem: 5736
- Metlin: METLIN3080
- DrugBank: DB09225
- ChEMBL: CHEMBL285802
- CAS: 1200591-33-8
- CAS: 26615-21-4
- PMhub: MS000240529
- medchemexpress: HY-103093
分类词条
相关代谢途径
Reactome(0)
BioCyc(0)
PlantCyc(0)
代谢反应
0 个相关的代谢反应过程信息。
Reactome(0)
BioCyc(0)
WikiPathways(0)
Plant Reactome(0)
INOH(0)
PlantCyc(0)
COVID-19 Disease Map(0)
PathBank(0)
PharmGKB(0)
0 个相关的物种来源信息
在这里通过桑基图来展示出与当前的这个代谢物在我们的BioDeep知识库中具有相关联信息的其他代谢物。在这里进行关联的信息来源主要有：
- PubMed: 来源于PubMed文献库中的文献信息，我们通过自然语言数据挖掘得到的在同一篇文献中被同时提及的相关代谢物列表，这个列表按照代谢物同时出现的文献数量降序排序，取前10个代谢物作为相关研究中关联性很高的代谢物集合展示在桑基图中。
- NCBI Taxonomy: 通过文献数据挖掘，得到的代谢物物种来源信息关联。这个关联信息同样按照出现的次数降序排序，取前10个代谢物作为高关联度的代谢物集合展示在桑吉图上。
- Chemical Taxonomy: 在物质分类上处于同一个分类集合中的其他代谢物
- Chemical Reaction: 在化学反应过程中，存在为当前代谢物相关联的生化反应过程中的反应底物或者反应产物的关联代谢物信息。
点击图上的相关代谢物的名称，可以跳转到相关代谢物的信息页面。
文献列表
- Mark J Henderson, Kathleen A Trychta, Shyh-Ming Yang, Susanne Bäck, Adam Yasgar, Emily S Wires, Carina Danchik, Xiaokang Yan, Hideaki Yano, Lei Shi, Kuo-Jen Wu, Amy Q Wang, Dingyin Tao, Gergely Zahoránszky-Kőhalmi, Xin Hu, Xin Xu, David Maloney, Alexey V Zakharov, Ganesha Rai, Fumihiko Urano, Mikko Airavaara, Oksana Gavrilova, Ajit Jadhav, Yun Wang, Anton Simeonov, Brandon K Harvey. A target-agnostic screen identifies approved drugs to stabilize the endoplasmic reticulum-resident proteome.
Cell reports.
2021 04; 35(4):109040. doi:
10.1016/j.celrep.2021.109040. [PMID: 33910017] - Cernam Tirumalesh, Dinesh Suram, Narendar Dudhipala, Nagaraj Banala. Enhanced Pharmacokinetic Activity of Zotepine via Nanostructured Lipid Carrier System in Wistar Rats for Oral Application.
Pharmaceutical nanotechnology.
2020; 8(2):148-160. doi:
10.2174/2211738508666200225113359. [PMID: 32096755] - Tobie D Lee, Olivia W Lee, Kyle R Brimacombe, Lu Chen, Rajarshi Guha, Sabrina Lusvarghi, Bethilehem G Tebase, Carleen Klumpp-Thomas, Robert W Robey, Suresh V Ambudkar, Min Shen, Michael M Gottesman, Matthew D Hall. A High-Throughput Screen of a Library of Therapeutics Identifies Cytotoxic Substrates of P-glycoprotein.
Molecular pharmacology.
2019 11; 96(5):629-640. doi:
10.1124/mol.119.115964. [PMID: 31515284] - Hisahiro Yoshida, Minori Takahashi, Misuzu Honda, Hideaki Amayasu, Masazumi Ando. Co-administration of Magnesium Oxide Reduces the Serum Concentration of Hydrophobic Basic Drugs in Patients Treated with Antipsychotic Drugs.
Biological & pharmaceutical bulletin.
2019; 42(6):1025-1029. doi:
10.1248/bpb.b18-00733. [PMID: 31155577] - Hung-Yu Chan, An-Sheng Lin, Kun-Po Chen, Jror-Serk Cheng, Ying-Yeh Chen, Chang-Jer Tsai. An open-label, randomized, controlled trial of zotepine and risperidone for acutely ill, hospitalized, schizophrenic patients with symptoms of agitation.
Journal of clinical psychopharmacology.
2013 Dec; 33(6):747-52. doi:
10.1097/jcp.0b013e31829e8168. [PMID: 24100785] - Manuel Maria de Carvalho, Carlos Góis. [Hyperprolactinemia in mentally ill patients].
Acta medica portuguesa.
2011 Nov; 24(6):1005-12. doi:
. [PMID: 22713195] - Tim Moons, Mariska de Roo, Stephan Claes, Geert Dom. Relationship between P-glycoprotein and second-generation antipsychotics.
Pharmacogenomics.
2011 Aug; 12(8):1193-211. doi:
10.2217/pgs.11.55. [PMID: 21843066] - Ming-Hong Hsieh, Wei-Wen Lin, Shao-Tsu Chen, Kao-Ching Chen, Kuang-Peng Chen, Nan-Ying Chiu, Chao Huang, Ching-Jui Chang, Cheng-Hsiu Lin, Te-Jen Lai. A 64-week, multicenter, open-label study of aripiprazole effectiveness in the management of patients with schizophrenia or schizoaffective disorder in a general psychiatric outpatient setting.
Annals of general psychiatry.
2010 Sep; 9(?):35. doi:
10.1186/1744-859x-9-35. [PMID: 20849577] - M Shobo, Y Kondo, H Yamada, T Mihara, N Yamamoto, M Katsuoka, K Harada, K Ni, N Matsuoka. Norzotepine, a major metabolite of zotepine, exerts atypical antipsychotic-like and antidepressant-like actions through its potent inhibition of norepinephrine reuptake.
The Journal of pharmacology and experimental therapeutics.
2010 Jun; 333(3):772-81. doi:
10.1124/jpet.110.166264. [PMID: 20223878] - Hung-Yu Chan, Shaw-Hua Jou, Yeong-Yuh Juang, Ching-Jui Chang, Jiahn-Jyh Chen, Chiung-Hsu Chen, Nan-Ying Chiu. A single-blind, comparative study of zotepine versus haloperidol in combination with a mood stabilizer for patients with moderate-to-severe mania.
Psychiatry and clinical neurosciences.
2010 Apr; 64(2):162-9. doi:
10.1111/j.1440-1819.2010.02066.x. [PMID: 20447012] - Kazuyoshi Nozaki, Issey Osaka, Hideya Kawasaki, Ryuichi Arakawa. Application of on-line electrochemistry/electrospray/tandem mass spectrometry to a quantification method for the antipsychotic drug zotepine in human serum.
Analytical sciences : the international journal of the Japan Society for Analytical Chemistry.
2009 Oct; 25(10):1197-201. doi:
10.2116/analsci.25.1197. [PMID: 19822962] - Linda Hanssens, Gilbert L'Italien, Jean-Yves Loze, Ronald N Marcus, Miranda Pans, Wendy Kerselaers. The effect of antipsychotic medication on sexual function and serum prolactin levels in community-treated schizophrenic patients: results from the Schizophrenia Trial of Aripiprazole (STAR) study (NCT00237913).
BMC psychiatry.
2008 Dec; 8(?):95. doi:
10.1186/1471-244x-8-95. [PMID: 19102734] - Jaromír Svestka, Oldrich Synek, Jana Tomanová, Irena Rodáková, Andrea Cejpková. Differences in the effect of second-generation antipsychotics on prolactinaemia: six weeks open-label trial in female in-patients.
Neuro endocrinology letters.
2007 Dec; 28(6):881-8. doi:
NULL. [PMID: 18063941] - Pierre Chue. Long-acting risperidone injection: efficacy, safety, and cost-effectiveness of the first long-acting atypical antipsychotic.
Neuropsychiatric disease and treatment.
2007 Feb; 3(1):13-39. doi:
10.2147/nedt.2007.3.1.13. [PMID: 19300536] - H Kirchherr, W N Kühn-Velten. Quantitative determination of forty-eight antidepressants and antipsychotics in human serum by HPLC tandem mass spectrometry: a multi-level, single-sample approach.
Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.
2006 Oct; 843(1):100-13. doi:
10.1016/j.jchromb.2006.05.031. [PMID: 16798119] - Reiji Yoshimura, Koji Shinkai, Yumiko Toyohira, Susumu Ueno, Nobuyuki Yanagihara, Jun Nakamura. Effects of zotepine and olanzapine on noradrenaline transporter in cultured bovine adrenal medullary cells.
Human psychopharmacology.
2005 Oct; 20(7):477-84. doi:
10.1002/hup.715. [PMID: 16158449] - Yu-Wei Chou, Wei-Shan Huang, Cheng-Chung Chen, Shun-Jin Lin, Hsin-Lung Wu, Su-Hwei Chen. Trace analysis of zotepine and its active metabolite in plasma by capillary electrophoresis with solid phase extraction and head-column field-amplified sample stacking.
Journal of chromatography. A.
2005 Sep; 1087(1-2):189-96. doi:
10.1016/j.chroma.2004.11.061. [PMID: 16130713] - John W Newcomer. Second-generation (atypical) antipsychotics and metabolic effects: a comprehensive literature review.
CNS drugs.
2005; 19 Suppl 1(?):1-93. doi:
10.2165/00023210-200519001-00001. [PMID: 15998156] - Kristina Melkersson, Marja-Liisa Dahl. Adverse metabolic effects associated with atypical antipsychotics: literature review and clinical implications.
Drugs.
2004; 64(7):701-23. doi:
10.2165/00003495-200464070-00003. [PMID: 15025545] - Carsten Kratzsch, Frank T Peters, Thomas Kraemer, Armin A Weber, Hans H Maurer. Screening, library-assisted identification and validated quantification of fifteen neuroleptics and three of their metabolites in plasma by liquid chromatography/mass spectrometry with atmospheric pressure chemical ionization.
Journal of mass spectrometry : JMS.
2003 Mar; 38(3):283-95. doi:
10.1002/jms.440. [PMID: 12644990] - Tilman Wetterling. [Hyperlipidemia--side-effect of the treatment with an atypical antipsychotic (zotepine)?].
Psychiatrische Praxis.
2002 Nov; 29(8):438-40. doi:
10.1055/s-2002-35507. [PMID: 12436365] - J Bickeboeller-Friedrich, H H Maurer. Screening for detection of new antidepressants, neuroleptics, hypnotics, and their metabolites in urine by GC-MS developed using rat liver microsomes.
Therapeutic drug monitoring.
2001 Feb; 23(1):61-70. doi:
10.1097/00007691-200102000-00012. [PMID: 11206046] - S Kapur, G Remington. Atypical antipsychotics: new directions and new challenges in the treatment of schizophrenia.
Annual review of medicine.
2001; 52(?):503-17. doi:
10.1146/annurev.med.52.1.503. [PMID: 11160792] - M Tatsumi, K Jansen, R D Blakely, E Richelson. Pharmacological profile of neuroleptics at human monoamine transporters.
European journal of pharmacology.
1999 Mar; 368(2-3):277-83. doi:
10.1016/s0014-2999(99)00005-9. [PMID: 10193665] - O Tanaka, T Kondo, K Otani, N Yasui, N Tokinaga, S Kaneko. Single oral dose kinetics of zotepine and its relationship to prolactin response and side effects.
Therapeutic drug monitoring.
1998 Feb; 20(1):117-9. doi:
10.1097/00007691-199802000-00021. [PMID: 9485566] - H Tokunaga, K Kudo, T Imamura, N Jitsufuchi, Y Ohtsuka, N Ikeda. Plasma concentrations of antipsychotic drugs in psychiatric inpatients.
Nihon hoigaku zasshi = The Japanese journal of legal medicine.
1997 Dec; 51(6):417-22. doi:
. [PMID: 9545754] - T Kondo, O Tanaka, K Otani, K Mihara, N Tokinaga, S Kaneko, K Chiba, T Ishizaki. Possible inhibitory effect of diazepam on the metabolism of zotepine, an antipsychotic drug.
Psychopharmacology.
1996 Oct; 127(4):311-4. doi:
10.1007/s002130050091. [PMID: 8923565] - O Tanaka, T Kondo, S Kaneko, K Mihara, K Otani, N Tokinaga. A method for rapid determination of zotepine by gas chromatography-mass spectrometry.
Therapeutic drug monitoring.
1996 Jun; 18(3):294-6. doi:
10.1097/00007691-199606000-00013. [PMID: 8738771] - O Tanaka. [Pharmacokinetics of zotepine and various factors affecting that of zotepine].
Nihon shinkei seishin yakurigaku zasshi = Japanese journal of psychopharmacology.
1996 Apr; 16(2):49-52. doi:
NULL. [PMID: 8905790] - S Ulrich, F P Meyer, B Bogerts. A capillary gas-liquid chromatographic method for the assay of the neuroleptic drug zotepine in human serum or plasma.
Journal of pharmaceutical and biomedical analysis.
1996 Feb; 14(4):441-9. doi:
10.1016/0731-7085(95)01637-6. [PMID: 8729643] - T Kondo, K Otani, M Ishida, O Tanaka, S Kaneko, Y Fukushima. Adverse effects of zotepine and their relationship to serum concentrations of the drug and prolactin.
Therapeutic drug monitoring.
1994 Apr; 16(2):120-4. doi:
10.1097/00007691-199404000-00002. [PMID: 7912012] - K Otani, T Kondo, S Kaneko, M Ishida, Y Fukushima. Correlation between prolactin response and therapeutic effects of zotepine in schizophrenic patients.
International clinical psychopharmacology.
1994; 9(4):287-9. doi:
10.1097/00004850-199400940-00008. [PMID: 7868851] - M Ishida. [Therapeutic and adverse effects of zotepine and their relationships with serum kinetics of the drug].
Yakubutsu, seishin, kodo = Japanese journal of psychopharmacology.
1993 Jun; 13(3):97-105. doi:
NULL. [PMID: 8237138] - M Kaneko, K Watanabe, H Kumashiro. Plasma ratios of tryptophan and tyrosine to other large neutral amino acids in manic-depressive patients.
The Japanese journal of psychiatry and neurology.
1992 Sep; 46(3):711-20. doi:
10.1111/j.1440-1819.1992.tb00546.x. [PMID: 1362591] - B Saletu, J Grünberger, P Anderer, K Chwatal. [Relation between blood levels and average quantitative EEG and psychometrically assessed pharmacodynamic changes following zotepine].
Fortschritte der Neurologie-Psychiatrie.
1991 Sep; 59 Suppl 1(?):45-55. doi:
10.1055/s-2007-1000735. [PMID: 1683340] - K Otani, T Hirano, T Kondo, S Kaneko, Y Fukushima, K Noda, Y Tashiro. Biperiden and piroheptine do not affect the serum level of zotepine, a new antipsychotic drug.
The British journal of psychiatry : the journal of mental science.
1990 Jul; 157(?):128-30. doi:
10.1192/bjp.157.1.128. [PMID: 1975759] - Y Higashi, Y Momotani, E Suzuki, T Kaku. Clinical and EEG studies of zotepine, a thiepine neuroleptic, on schizophrenic patients.
Pharmacopsychiatry.
1987 Feb; 20(1 Spec No):8-11. doi:
10.1055/s-2007-1017124. [PMID: 2883687] - B Saletu, J Grünberger, L Linzmayer, P Anderer. Comparative placebo-controlled pharmacodynamic studies with zotepine and clozapine utilizing pharmaco-EEG and psychometry.
Pharmacopsychiatry.
1987 Feb; 20(1 Spec No):12-27. doi:
10.1055/s-2007-1017125. [PMID: 2883677] - W W Fleischhacker, B Unterweger, C Barnas, C Stuppäck, H Hinterhuber. Results of an open phase II study with zotepine--a new neuroleptic compound.
Pharmacopsychiatry.
1987 Feb; 20(1 Spec No):64-6. doi:
10.1055/s-2007-1017133. [PMID: 2883686] - K Yamada, N Matsuo, T Matsuda, M Tanaka, T Furukawa, T Koja, T Fukuda. Effects of new neuroleptics, isofloxythepin and zotepine, on post-decapitation convulsions and prolactin secretion in rats.
Pharmacology, biochemistry, and behavior.
1986 May; 24(5):1445-9. doi:
10.1016/0091-3057(86)90208-x. [PMID: 2873590] - H Yoshida, H Kaiya, T Kondo, F Sanpei, N Takeda, K Takeuchi. [Effects of zotepine, a psychotropic agent, on the serum uric acid level of inpatients at a psychiatric hospital].
Yakubutsu, seishin, kodo = Japanese journal of psychopharmacology.
1982 Dec; 2(2):69-76. doi:
NULL. [PMID: 6141682] - K Noda, A Suzuki, M Okui, H Noguchi, M Nishiura, N Nishiura. Pharmacokinetics and metabolism of 2-chloro-11-(2-dimethylaminoethoxy)-dibenzo[b,f]thiepine (zotepine) in rat, mouse, dog and man.
Arzneimittel-Forschung.
1979; 29(10):1595-600. doi:
NULL. [PMID: 42414]